| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4283738
Max Phase: Preclinical
Molecular Formula: C22H21F3N2O4S
Molecular Weight: 466.48
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: O=S(=O)(CC(F)(F)F)N(Cc1ccco1)CC(O)Cn1c2ccccc2c2ccccc21
Standard InChI: InChI=1S/C22H21F3N2O4S/c23-22(24,25)15-32(29,30)26(14-17-6-5-11-31-17)12-16(28)13-27-20-9-3-1-7-18(20)19-8-2-4-10-21(19)27/h1-11,16,28H,12-15H2
Standard InChI Key: HMVNBKCGTGVDLP-UHFFFAOYSA-N
Associated Targets(Human)
CRY2 Tbio Cry1/Cry2 (247 Activities)
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 466.48 | Molecular Weight (Monoisotopic): 466.1174 | AlogP: 4.14 | #Rotatable Bonds: 8 |
| Polar Surface Area: 75.68 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 9.64 | CX Basic pKa: | CX LogP: 3.32 | CX LogD: 3.31 |
| Aromatic Rings: 4 | Heavy Atoms: 32 | QED Weighted: 0.42 | Np Likeness Score: -1.22 |
References
| 1. (2016) Carbazole-containing sulfonamides as cryptochrome modulators, |
Source
Source(1):